- Home
- DXPE vs QURE Comparison
DXPE vs QURE Comparison
Compare DXPE & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXPE | QURE |
|---|---|---|
| Founded | 1908 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DXPE | QURE |
|---|---|---|
| Price | $114.63 | $22.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | ★ $95.00 | $58.55 |
| AVG Volume (30 Days) | 136.3K | ★ 2.5M |
| Earning Date | 03-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.17 | N/A |
| EPS | ★ 5.27 | N/A |
| Revenue | ★ $1,959,889,000.00 | $15,751,000.00 |
| Revenue This Year | $11.87 | N/A |
| Revenue Next Year | $7.39 | $153.45 |
| P/E Ratio | $21.51 | ★ N/A |
| Revenue Growth | ★ 12.76 | N/A |
| 52 Week Low | $67.68 | $7.76 |
| 52 Week High | $130.97 | $71.50 |
Technical Indicators
Market Signals| Indicator | DXPE | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 43.25 |
| Support Level | $100.01 | $22.11 |
| Resistance Level | $117.00 | $28.77 |
| Average True Range (ATR) | 4.70 | 1.56 |
| MACD | 0.15 | 0.27 |
| Stochastic Oscillator | 88.76 | 18.37 |
Price Performance
Historical ComparisonAbout DXPE DXP Enterprises Inc.
DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.